1706.7000 -11.90 (-0.69%)
NSE Jul 04, 2025 15:31 PM
Volume: 82,405
 

1706.70
-0.69%
Prabhudas Lilladhar
Strong FY26 guidance with +15% revenue growth with 36% OPM. up 70% YoY). Eris has opted for inorganic route to diversify and scale up expect margins to scale up from the current level of 35% as revenue scales up from recent acquisitions, which are currently operating at sub-optimal profitability. The company has multiple growth levers such as broad-based...
Eris Lifesciences Ltd. is trading above all available SMAs
More from Eris Lifesciences Ltd.
Recommended